COYA Coya Therapeutics Inc

Price (delayed)

$4.86

Market cap

$114M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.15

Enterprise value

$63.28M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 26

Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, ...

Highlights
The gross profit has soared by 115% year-on-year
COYA's revenue has soared by 115% YoY
The EPS is up by 9% since the previous quarter but it has declined by 7% year-on-year
COYA's net income is down by 23% YoY

Key stats

What are the main financial stats of COYA

COYA stock price

How has the Coya Therapeutics stock price performed over time
Intraday
4.74%
1 week
0.62%
1 month
14.08%
1 year
-14.89%
YTD
-16.21%
QTD
23.35%

Financial performance

How have Coya Therapeutics's revenue and profit performed over time
Revenue
$7.94M
Gross profit
$7.94M
Operating income
-$22.52M
Net income
-$21.13M
Gross margin
100%
Net margin
-266.1%
The gross profit has soared by 115% year-on-year
COYA's revenue has soared by 115% YoY
Coya Therapeutics's operating margin has increased by 46% YoY
Coya Therapeutics's net margin has increased by 43% YoY

Price vs fundamentals

How does COYA's price correlate with its fundamentals

Growth

What is Coya Therapeutics's growth rate over time

Valuation

What is Coya Therapeutics stock price valuation
P/E
N/A
P/B
2.33
P/S
13.86
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.97
The EPS is up by 9% since the previous quarter but it has declined by 7% year-on-year
The company's equity rose by 47% YoY and by 14% QoQ
The P/B is 23% below the last 4 quarters average of 2.9
COYA's revenue has soared by 115% YoY
COYA's P/S is 81% below its last 4 quarters average of 68.6

Efficiency

How efficient is Coya Therapeutics business performance
The return on sales is up by 45% year-on-year
Coya Therapeutics's return on equity has decreased by 17% YoY but it has increased by 11% QoQ
The ROA has contracted by 16% YoY but it has grown by 9% from the previous quarter

Dividends

What is COYA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for COYA.

Financial health

How did Coya Therapeutics financials performed over time
The company's quick ratio has surged by 79% QoQ and by 75% YoY
COYA's current ratio has surged by 77% since the previous quarter and by 70% year-on-year
Coya Therapeutics's debt is 100% less than its equity
The company's equity rose by 47% YoY and by 14% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.